Efg Asset Management (North America) Corp. Alkermes Plc. Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Alkermes Plc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 129,662 shares of ALKS stock, worth $4.51 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
129,662
Previous 81,761
58.59%
Holding current value
$4.51 Million
Previous $2.29 Million
62.98%
% of portfolio
0.53%
Previous 0.39%
Shares
12 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$643 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$426 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$307 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$263 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.71B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...